Bitcoin dominance shed another 1.31% in the past 24 hours, taking the percentage share of the largest crypto asset to 58.61%. This drop below the 60% mark came as a result of the altcoin market rally with Ethereum leading gains, signaling capital rotation into altcoins. Cardano and Injective are two projects that are showing promise as the transition into what analysts are referring to as a mini alt season kickstarts.

Remittix (RTX) is another project under the radar of market experts. This payment protocol was engineered to close a $190 trillion global payment gap between traditional banking and crypto, allowing for seamless end-to-end transfers between any two entities anywhere in the world.

We will examine these three crypto projects and how they stand a chance to profit from capital rotation amid the downward spiral of Bitcoin dominance.

Cardano: Technicals and Retail Behaviour Fuel Bullish Sentiment

One altcoin in particular that is drawing the attention of institutional and retail investors is Cardano. Smart money has continued moving towards this asset and other alts as BTC consolidates near $119K. In the last 24 hours, ADA jumped 13%, breaking through critical resistance levels and sparking talk of a potential breakout toward the $1.50 price level.

Analysts are pointing to a golden cross formation on the charts where the 50-day MA crosses above the 200-day MA as a sign of sustained bullish momentum. Open interest in ADA futures has also surged, suggesting there is still room for upside movements. An optimistic Cardano price prediction hints at a move toward $1, especially if Bitcoin dominance continues to fall.

Injective: Pre-IPO Trading Sparks Market Excitement

The current market conditions surrounding Bitcoin dominance strongly favor the start of an altcoin season and Injective is one to watch. The asset hit a five-month high after retesting a crucial resistance level, before sideways movements in the final days of July.

Source: X

Injective is up by 10.2 % over the last 24 hours, trading above $15.59. Several analysts have included Injective in their crypto watchlist, noting that pre-IPO trading on Injective will launch this week, potentially increasing attention and demand for INJ.

Natives have also expressed bullish sentiment on INJ, with on-chain data showing continuous accumulation since last week. Technicals point to a near-term move toward $16 and then $22, reinforcing the strong short-term potential of Injective in this cycle.

Remittix: Huge Market Potential in Q3

Remittix is a cross-chain DeFi solution built to close a $190 trillion global payment gap between traditional banking and crypto. Experts have taken note of some of its features that they believe will play a massive role in its global adoption and long-term success.

Two of them include:

• On the Remttix platform, users are one-click away from instant crypto-to-fiat transfers across multiple payment rails, which reduces processing time and eliminates reliance on costly intermediaries.
• RTX will offer adopters seamless transaction tracking with real-time exchange rate data to optimize remittance efficiency.

Besides, Remittix’s presale is one of the hottest so far, scooping millions of dollars worth of smart money, mirroring its market potential when it launches later in Q3.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/

Socials: https://linktr.ee/remittix

$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway